Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Shanafelt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Biotechnology|February 7, 2003
Receptor-based design of cytokine therapeuticsA B Shanafelt
Biotechniques|September 1, 1991
An improved method for visualizing baculovirus plaques in cell agarose overlaysA B Shanafelt
Oncogene|February 1, 1993
GM-CSF receptor: interactions and activationR A Kastelein, A B Shanafelt
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Identification of critical regions in mouse granulocyte-macrophage colony-stimulating factor by scanning-deletion analysisA B Shanafelt, R A Kastelein
The Journal of Biological Chemistry|December 15, 1992
High affinity ligand binding is not essential for granulocyte-macrophage colony-stimulating factor receptor activationA B Shanafelt, R A Kastelein
The Journal of Biological Chemistry|July 25, 1991
Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificityA B Shanafelt, K E Johnson, R A Kastelein
The EMBO Journal|December 1, 1991
The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptorsA B Shanafelt, A Miyajima, T Kitamura, et al.
Plasmid|May 1, 1987
Cloning and overexpression of the colicin E1 immunity geneA B Shanafelt, K M Goldman, R A Kastelein, et al.
The Journal of Biological Chemistry|July 15, 1992
Requirement of hydrophilic amino-terminal residues for granulocyte-macrophage colony-stimulating factor bioactivity and receptor bindingN J Meropol, S W Altmann, A B Shanafelt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
An immune cell-selective interleukin 4 agonistA B Shanafelt, C P Forte, J J Kasper, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|February 7, 2003
Receptor-based design of cytokine therapeuticsA B Shanafelt
Biotechniques|September 1, 1991
An improved method for visualizing baculovirus plaques in cell agarose overlaysA B Shanafelt
Oncogene|February 1, 1993
GM-CSF receptor: interactions and activationR A Kastelein, A B Shanafelt
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Identification of critical regions in mouse granulocyte-macrophage colony-stimulating factor by scanning-deletion analysisA B Shanafelt, R A Kastelein
The Journal of Biological Chemistry|December 15, 1992
High affinity ligand binding is not essential for granulocyte-macrophage colony-stimulating factor receptor activationA B Shanafelt, R A Kastelein
The Journal of Biological Chemistry|July 25, 1991
Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificityA B Shanafelt, K E Johnson, R A Kastelein
The EMBO Journal|December 1, 1991
The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptorsA B Shanafelt, A Miyajima, T Kitamura, et al.
Plasmid|May 1, 1987
Cloning and overexpression of the colicin E1 immunity geneA B Shanafelt, K M Goldman, R A Kastelein, et al.
The Journal of Biological Chemistry|July 15, 1992
Requirement of hydrophilic amino-terminal residues for granulocyte-macrophage colony-stimulating factor bioactivity and receptor bindingN J Meropol, S W Altmann, A B Shanafelt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
An immune cell-selective interleukin 4 agonistA B Shanafelt, C P Forte, J J Kasper, et al.
Pageof 2